GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (CHIX:KURNz) » Definitions » Common Stock

Kuros Biosciences (CHIX:KURNZ) Common Stock : CHF3.71 Mil (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Kuros Biosciences Common Stock?

Kuros Biosciences's quarterly common stock increased from Jun. 2023 (CHF3.66 Mil) to Dec. 2023 (CHF3.68 Mil) and increased from Dec. 2023 (CHF3.68 Mil) to Jun. 2024 (CHF3.71 Mil).

Kuros Biosciences's annual common stock increased from Dec. 2021 (CHF3.28 Mil) to Dec. 2022 (CHF3.66 Mil) and increased from Dec. 2022 (CHF3.66 Mil) to Dec. 2023 (CHF3.68 Mil).


Kuros Biosciences Common Stock Historical Data

The historical data trend for Kuros Biosciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Common Stock Chart

Kuros Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.47 32.81 3.28 3.66 3.68

Kuros Biosciences Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 3.66 3.66 3.68 3.71

Kuros Biosciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Kuros Biosciences Business Description

Traded in Other Exchanges
Address
Wagistrasse 25, Schlieren, Zurich, CHE, 8952
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.

Kuros Biosciences Headlines

No Headlines